RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @jcwirth: @DLeonhardt Mucosal immunity (nose and throat) relies on IgA antibodies. Natural infection gives these, the vaccines don't. Th…
@Peter_Nater @SHomburg Das zu den klinischen Studien kann man auch hier nachlesen https://t.co/33A7kjFG2t
RT @jcwirth: @DLeonhardt Mucosal immunity (nose and throat) relies on IgA antibodies. Natural infection gives these, the vaccines don't. Th…
SARS-CoV-2 vaccines in development | Nature https://t.co/5gKddpFQGp
RT @jcwirth: @DLeonhardt Mucosal immunity (nose and throat) relies on IgA antibodies. Natural infection gives these, the vaccines don't. Th…
Sars 2 Vaccine 20 https://t.co/DTJOTGcNfR
@DLeonhardt Mucosal immunity (nose and throat) relies on IgA antibodies. Natural infection gives these, the vaccines don't. The vaccine will certainly help reduce spread, but it's a very open question as to what degree: https://t.co/ePf8Qx8OMC
Aşı çalışmalarının nasıl hızla Faz-3 başlangıcına geldiğini gösteren grafik. Teknoloji ve finansman farklılığı sadece ilk aşamayı açıklar. Zamana bağlı olarak yeterli sayıda denekle sonuç almayı hızlandırmak mümkün mü aşılar yeterince incelenmedi mi? h
@satai @karel24413829 @jiribulan @SeznamZpravy Jojo, ze spike je idealni cil pro protilatky se opravdu vedelo uz "diky" sarsu a mersu. I to pomohlo urychlit vyvoj vakcin. Jinak hezky review k vyvoji vakcin na sars-cov-2 je tady: https://t.co/SMhbz1MSQZ
Referencias. 1.- Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020). https://t.co/KLsQDzuqh3 2.- Kaur S.P., Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus research. 2020. https://t.co/iiLovR6jst (14/14)
RT @florian_krammer: 1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sur…
@ORTAISOL Es que ya tenían muchos años trabajando en una vacuna universal para SARS y MERS. Lo que hicieron fue utilizar la misma tecnología y aplicarla al SARS-Cov-2 (Covid-19). Hay que leer antes de opinar. https://t.co/40cQSNP91u
Bukvalno potreban "Opstanak", glas Žarka Đurovića i da ovo neko recimo ovo stručno prevede i plastično pojasni građanima. https://t.co/sjsWKL6ho5
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
@dvir_a לפי @florian_krammer גם החיסון של אסטרה-זנקה לא אמור היה לעבוד בתרסיס, והתוצאות האלו ממש מרשימות! אולי צריך לנסות גם עם RNA, מי יודע, אולי זה יעבוד. וגם לחיסון של המכון הביולוגי יש פוטנציאל לעבוד בתרסיס.. https://t.co/xnR5QJ8VUT
@fishmyman @fcarusoconrotto @ThaiEnquirer @florian_krammer His writeup in Nature about all(?) the vaccines in development is an excellent primer. Though it’s from back in September, so only looks at results of animal models. https://t.co/coszsJtetI
RT @florian_krammer: 1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sur…
@bijans Thanks! I was surprised to learn that the AZ vaccine's spike protein is not prefusion-stabilized. AZD1222 encodes "a wild-type version of the spike protein (that is, containing no stabilizing mutations and with the polybasic cleavage site present)
3c. The interesting counterargument involves requirement of IgA for upper resp tract mucosal immunity (vs IgG to prevent LRT symptomatic disease). However, as @leela_davies points out, IgG-generating vaccines prevent transmission in other resp viruses htt
@crazy_henkie @XqnTi7m @hnkdvrs @telegraaf Leer jezelf eerst even de les, voordat je zonder enige kennis van zaken tegen anderen begint te toeteren: https://t.co/hTskz1EwJM
RT @yousitonmyspot: @MaxlWerner "This could lead to vaccines that, although protecting from symptomatic disease, might still enable transmi…
@MaxlWerner "This could lead to vaccines that, although protecting from symptomatic disease, might still enable transmission of the virus. In this case, the amount of virus shed and the duration of shedding might be reduced." @florian_krammer, https://t.c
@grz79 @PolitycznaJ @KazanowskiKamil @micalrg 1. Że N=1 dostanie, czy 2. że w ogóle opracują ? W/g mnie 1 nie, 2 tak. W przewidywalnym terminie. https://t.co/7RTJj706aZ https://t.co/HWPNNP1ECr
RT @PaulHoskisson: #SARS-CoV-2 #vaccines in development #Papers365 https://t.co/5oEny8IN4Y
RT @PaulHoskisson: #SARS-CoV-2 #vaccines in development #Papers365 https://t.co/5oEny8IN4Y
RT @PaulHoskisson: #SARS-CoV-2 #vaccines in development #Papers365 https://t.co/5oEny8IN4Y
#SARS-CoV-2 #vaccines in development #Papers365 https://t.co/5oEny8IN4Y
RT @SanjatKanjilal: @AaronRichterman In @florian_krammer's fantastic review of #COVID19 vaccines from back in September (https://t.co/UJmR0…
RT @SanjatKanjilal: @AaronRichterman In @florian_krammer's fantastic review of #COVID19 vaccines from back in September (https://t.co/UJmR0…
@AaronRichterman In @florian_krammer's fantastic review of #COVID19 vaccines from back in September (https://t.co/UJmR0OXoJD), I read that sterilizing immunity of the upper respiratory tract requires IgA. These vax only generate IgG but if they reduce asx
RT @farismgazali: Bagaimana Perkembangan Vaksin SARS-CoV-2 hingga saat ini? Apakah vaksin berbahaya? – A thread Kalo mau info detailnya bi…
RT @farismgazali: Bagaimana Perkembangan Vaksin SARS-CoV-2 hingga saat ini? Apakah vaksin berbahaya? – A thread Kalo mau info detailnya bi…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
@ElieJarrougeMD Does this mean you believe the vaccine will reduce transmission even though it wasn't shown in the trials and it is traditionally hard to get mucosal immunity via intramural vaccination? https://t.co/UXTAA3aMJj
👏👏👏
@james_clark He also published a proper version of it in Nature. Though for some twisted reason I still preferred reading it in Twitter thread form 🤷🏻♂️😂 https://t.co/coszsJtetI
RT @florian_krammer: 1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sur…
This is a very useful tutorial on Covid vaccines h/t @sobri
@james_clark Have to get down past tweet 40ish to start getting to the numbers.
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
@charlesarthur @Dr2NisreenAlwan @maggiephilbin @florian_krammer and @VirusesImmunity might also be able to help. Some further reading: https://t.co/qB5R7otYos & https://t.co/Tsc6FIBo6D
@MonicaGandhi9 @NahasNewman Here is a paper discussion how mucosal immunity is hard to obtain from intramuscular vaccination. Are you disagreeing with this analysis? https://t.co/CBAa05gL4D
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
Mucosal and systemic immune responses to natural infection with respiratory viruses and to vaccination.⤵️
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
RT @mmw_lmw: #SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awH…
#SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature https://t.co/awHJilODv3 | #2020_ReCapOct https://t.co/G5kzEC4NNO
RT @florian_krammer: 1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sur…
RT @florian_krammer: 1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sur…
@redcatrun @Zeeorbiter @chrischirp If the search for understanding is genuine, try the helpful tweetorial from @florian_krammer here and follow the various links for more detail and updates.
@NovateurBio ’s #COVID19 resource centre is dedicated to providing the most current information with 700+ top ranking articles, categorized to answer any questions related to COVID-19. Visit now: https://t.co/264uarNTzf https://t.co/ZmLKw0aHep
Awesome COVID-19 Tweetorial. #COVID19vaccine
@Karl_Lauterbach Kurze Übersicht über Impfstoffbestellungen der EU. Hauptfehler war viel zu späte Bestellung der mRNA-Impfstoffe, obwohl schon lange extrem erfolgversprechende Daten aus den Phase1/2-Studien vorlagen und von Experten darauf hingewiesen wurd
From late September so a bit outdated https://t.co/cHACR2CktF https://t.co/aO2cwyOJzM
RT @MarionKoopmans: Nice explanation of the accelerated timeline for vaccine development. Acceleration but not cutting corners https://t.co…
@astupple Re “prevent transmission” … apparently IM injected vaccines don’t induce the secretory IgA that confers mucosal immunity. https://t.co/6ylmVMC31z https://t.co/sLtLq4oawP https://t.co/YncHOFNJ8T
RT @Ayomidejoe: One of the most significant concerns raised about the COVID vaccine has been around why it was developed so fast and if the…
RT @Ayomidejoe: One of the most significant concerns raised about the COVID vaccine has been around why it was developed so fast and if the…
RT @anagazquezg: @Gonzaloside Claro, ¿qué estudios quieres exactamente? Aquí tienes varios donde se aísla el virus: https://t.co/WVaRweZav…
RT @Ayomidejoe: One of the most significant concerns raised about the COVID vaccine has been around why it was developed so fast and if the…
One of the most significant concerns raised about the COVID vaccine has been around why it was developed so fast and if the speed of development could be an issue around its safety. This article https://t.co/9LDWpE6Y8S addresses aspects of that... #vaccin
@DallinFoxdal @Biohazard3737 @CloisterRes A quick glance through these are really illuminating when you compare to some of the other comparable studies even for the mRNA candidates. @Dereklowe did an awesome job explaining NVAX's strengths here too: https
@nascar_girl_24 @Suttons49 spend some time reading this https://t.co/V22NxXqrDD
Sars 2 Sinofarm 7 https://t.co/DTJOTGcNfR
@KregarSpela @BojankaStern @MuriMursic Vektorska cepiva ne delajo po principu oslabljenega virusa. Fundacija Gavi ima dobro razloženo https://t.co/5CflvbhxL8 Ugledni virolog Florian Krammer je sept. naredil pregled vseh cepiv, ki so bila v naprednejši fazi
RT @florian_krammer: 1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sur…
RT @Thomas_Binder: No young low risk person (IFR 0.01%, children 0.00%) needs a vaccination and the only "vaccination" against COVID-19 tha…
RT @Thomas_Binder: No young low risk person (IFR 0.01%, children 0.00%) needs a vaccination and the only "vaccination" against COVID-19 tha…
RT @Thomas_Binder: No young low risk person (IFR 0.01%, children 0.00%) needs a vaccination and the only "vaccination" against COVID-19 tha…